The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association

In the 9(th) ETA-CRN Meeting (September 2009, Lisbon) some recommendations from the American Thyroid Association (ATA) guidelines for the management of medullary thyroid cancer (MTC) were discussed by an European Panel of Experts (EPE). Among the 12 ATA recommendations related to hereditary MTC and...

Descripción completa

Detalles Bibliográficos
Autores principales: Fugazzola, Laura, De Leo, Simone, Perrino, Michela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599734/
https://www.ncbi.nlm.nih.gov/pubmed/23514012
http://dx.doi.org/10.1186/1756-6614-6-S1-S8
Descripción
Sumario:In the 9(th) ETA-CRN Meeting (September 2009, Lisbon) some recommendations from the American Thyroid Association (ATA) guidelines for the management of medullary thyroid cancer (MTC) were discussed by an European Panel of Experts (EPE). Among the 12 ATA recommendations related to hereditary MTC and to the optimal range of RET mutations to be tested (recommendations 1-5 and 9-15), 7 were shared and 5 were not shared by the EPE. In the present paper, the related comments and suggestions will be reported and discussed.

Ejemplares similares